Emma Walmsley became the chief executive of GlaxoSmithKline 22 months ago, looking like the opposite of a pharma insider: She was, instead, steeped in the business of selling toothpaste and Tums. Appearances may have been deceiving — because she’s betting on drugs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,